.jpg)
![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
AstraZeneca has great ambitions for its mid-stage oral cholesterol drug, believi...
The departure of one of the FDA’s highest-profile regulators, whose career was d...
Phase 2 results on Eli Lilly’s experimental heart disease drug showed it could b...
Plus, news about Opthea, Apollomics, LaunXP and AstraZeneca: LifeMine redu...
Google’s bet on AI in drug discovery just got a lot bigger. Isomorphic Labs ...
A New York City drug developer led by well-known executives and backed by some o...
Isomorphic Labs, one of the leading AI-driven drug discovery companies within Al...
Transcend Therapeutics’ PTSD treatment succeeded in a mid-stage study, propellin...
BiomX’s antibacterial virus candidate has reduced the size of foot ulcers in pat...
SV Health Investors, fresh off a $250 million fund for dementia-focused biotechs...
Vertex Pharmaceuticals announced Friday afternoon that it won't move forward wit...
Welcome back to Endpoints Weekly, where we recap the week’s biggest news from th...
Peter Marks, the head of the FDA's Center for Biologics Evaluation and Research ...
Novartis’ prostate cancer radiopharmaceutical Pluvicto has netted a highly antic...
On Tuesday, drug discoverer and biotech entrepreneur Alpha Lee told scientists a...
Lykos Therapeutics’ interim CEO Michael Mullette is planning to step down, accor...